. 2006 Jul 5;60(5):500–503. doi: 10.1136/jcp.2006.040170

Table 1 Assessable cores.

Marker	One core*	%†	Two cores‡	%†	Three cores§	%†	Total assessable	%
ER	3	7	6	15	32	78	38	90
PR	1	2	10	24	30	73	40	98
p53	2	5	6	15	33	81	39	95
EMA	1	2	9	22	31	76	40	98

EMA, epithelial membrane antigen; OR, oestrogen receptor; PR, progesterone receptor.

*Number of cases with one assessable core.

†n = 41 patients.

‡Number of cases with two assessable cores.

§Number of cases with three assessable cores.

Marker	One core*	%†	Two cores‡	%†	Three cores§	%†	Total assessable	%
ER	3	7	6	15	32	78	38	90
PR	1	2	10	24	30	73	40	98
p53	2	5	6	15	33	81	39	95
EMA	1	2	9	22	31	76	40	98

Marker	One core*	%†	Two cores‡	%†	Three cores§	%†	Total assessable	%
ER	3	7	6	15	32	78	38	90
PR	1	2	10	24	30	73	40	98
p53	2	5	6	15	33	81	39	95
EMA	1	2	9	22	31	76	40	98

Marker	One core*	%†	Two cores‡	%†	Three cores§	%†	Total assessable	%
ER	3	7	6	15	32	78	38	90
PR	1	2	10	24	30	73	40	98
p53	2	5	6	15	33	81	39	95
EMA	1	2	9	22	31	76	40	98